{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:53:16Z","timestamp":1781902396749,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["NS074312"],"award-info":[{"award-number":["NS074312"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001671","name":"Hereditary Disease Foundation","doi-asserted-by":"crossref","award":["Leslie Gehry Brenner Award"],"award-info":[{"award-number":["Leslie Gehry Brenner Award"]}],"id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016206","name":"UCLA Clinical and Translational Science Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016206","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Anonymous donation from an HD family"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In Huntington\u2019s disease (HD), the mutant Huntingtin (mHTT) is postulated to mediate template-based aggregation that can propagate across cells. It has been difficult to quantitatively detect such pathological seeding activities in patient biosamples, e.g. cerebrospinal fluids (CSF), and study their correlation with the disease manifestation. Here we developed a cell line expressing a domain-engineered mHTT-exon\u00a01 reporter, which showed remarkably high sensitivity and specificity in detecting mHTT seeding species in HD patient biosamples. We showed that the seeding-competent mHTT species in HD CSF are significantly elevated upon disease onset and with the progression of neuropathological grades. Mechanistically, we showed that mHTT seeding activities in patient CSF could be ameliorated by the overexpression of chaperone DNAJB6 and by antibodies against the polyproline domain of mHTT. Together, our study developed a selective and scalable cell-based tool to investigate mHTT seeding activities in HD CSF, and demonstrated that the CSF mHTT seeding species are significantly associated with certain disease states. This seeding activity can be ameliorated by targeting specific domain or proteostatic pathway of mHTT, providing novel insights into such pathological activities.<\/jats:p>","DOI":"10.1038\/s41598-020-77164-1","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T11:11:54Z","timestamp":1605870714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Disease-related Huntingtin seeding activities in cerebrospinal fluids of Huntington\u2019s disease patients"],"prefix":"10.1038","volume":"10","author":[{"given":"C. Y. Daniel","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koning","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Stricos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Langfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina H.","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etty P.","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry V.","family":"Vinters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Paul","family":"Vonsattel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy S.","family":"Wexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Frydman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. William","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"77164_CR1","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990\u20131993. https:\/\/doi.org\/10.1126\/science.277.5334.1990 (1997).","journal-title":"Science"},{"key":"77164_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805\u2013810. https:\/\/doi.org\/10.1038\/nature02998 (2004).","journal-title":"Nature"},{"key":"77164_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1326-2-8","volume":"2","author":"X Gu","year":"2007","unstructured":"Gu, X. et al. Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington\u2019s disease. Mol. Neurodegener. 2, 8. https:\/\/doi.org\/10.1186\/1750-1326-2-8 (2007).","journal-title":"Mol. Neurodegener."},{"key":"77164_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","volume":"46","author":"X Gu","year":"2005","unstructured":"Gu, X. et al. Pathological cell\u2013cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46, 433\u2013444. https:\/\/doi.org\/10.1016\/j.neuron.2005.03.025 (2005).","journal-title":"Neuron"},{"key":"77164_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2017.08.009","volume":"171","author":"FJB Bauerlein","year":"2017","unstructured":"Bauerlein, F. J. B. et al. In situ architecture and cellular interactions of PolyQ inclusions. Cell 171, 179\u2013187. https:\/\/doi.org\/10.1016\/j.cell.2017.08.009 (2017).","journal-title":"Cell"},{"key":"77164_CR6","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.celrep.2018.07.017","volume":"24","author":"K Pircs","year":"2018","unstructured":"Pircs, K. et al. Huntingtin aggregation impairs autophagy, leading to Argonaute-2 accumulation and global MicroRNA dysregulation. Cell Rep. 24, 1397\u20131406. https:\/\/doi.org\/10.1016\/j.celrep.2018.07.017 (2018).","journal-title":"Cell Rep."},{"key":"77164_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.celrep.2017.04.029","volume":"19","author":"YM Ramdzan","year":"2017","unstructured":"Ramdzan, Y. M. et al. Huntingtin inclusions trigger cellular quiescence, deactivate apoptosis, and lead to delayed necrosis. Cell Rep. 19, 919\u2013927. https:\/\/doi.org\/10.1016\/j.celrep.2017.04.029 (2017).","journal-title":"Cell Rep."},{"key":"77164_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/78054","volume":"25","author":"H Li","year":"2000","unstructured":"Li, H., Li, S. H., Johnston, H., Shelbourne, P. F. & Li, X. J. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat. Genet. 25, 385\u2013389. https:\/\/doi.org\/10.1038\/78054 (2000).","journal-title":"Nat. Genet."},{"key":"77164_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat7108","author":"LM Byrne","year":"2018","unstructured":"Byrne, L. M. et al. Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington\u2019s disease. Transl. Med. Sci. https:\/\/doi.org\/10.1126\/scitranslmed.aat7108 (2018).","journal-title":"Transl. Med. Sci."},{"key":"77164_CR10","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI80743","volume":"125","author":"EJ Wild","year":"2015","unstructured":"Wild, E. J. et al. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients. J. Clin. Invest. 125, 1979\u20131986. https:\/\/doi.org\/10.1172\/JCI80743 (2015).","journal-title":"J. Clin. Invest."},{"key":"77164_CR11","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J. et al. Targeting huntingtin expression in patients with Huntington\u2019s disease. N. Engl. J. Med. 380, 2307\u20132316. https:\/\/doi.org\/10.1056\/NEJMoa1900907 (2019).","journal-title":"N. Engl. J. Med."},{"key":"77164_CR12","doi-asserted-by":"publisher","first-page":"e96854","DOI":"10.1371\/journal.pone.0096854","volume":"9","author":"D Macdonald","year":"2014","unstructured":"Macdonald, D. et al. Quantification assays for total and polyglutamine-expanded huntingtin proteins. PLoS ONE 9, e96854. https:\/\/doi.org\/10.1371\/journal.pone.0096854 (2014).","journal-title":"PLoS ONE"},{"key":"77164_CR13","doi-asserted-by":"publisher","first-page":"e0213521","DOI":"10.1371\/journal.pone.0213521","volume":"14","author":"W Reindl","year":"2019","unstructured":"Reindl, W. et al. Meso scale discovery-based assays for the detection of aggregated huntingtin. PLoS ONE 14, e0213521. https:\/\/doi.org\/10.1371\/journal.pone.0213521 (2019).","journal-title":"PLoS ONE"},{"key":"77164_CR14","doi-asserted-by":"publisher","first-page":"e0189891","DOI":"10.1371\/journal.pone.0189891","volume":"12","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss, D. J. et al. Quantification of huntingtin protein species in Huntington\u2019s disease patient leukocytes using optimised electrochemiluminescence immunoassays. PLoS ONE 12, e0189891. https:\/\/doi.org\/10.1371\/journal.pone.0189891 (2017).","journal-title":"PLoS ONE"},{"key":"77164_CR15","doi-asserted-by":"publisher","first-page":"12166","DOI":"10.1038\/srep12166","volume":"5","author":"AL Southwell","year":"2015","unstructured":"Southwell, A. L. et al. Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression. Sci. Rep. 5, 12166. https:\/\/doi.org\/10.1038\/srep12166 (2015).","journal-title":"Sci. Rep."},{"key":"77164_CR16","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray, M. et al. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J. Neurosci. 28, 6182\u20136195. https:\/\/doi.org\/10.1523\/JNEUROSCI.0857-08.2008 (2008).","journal-title":"J. Neurosci."},{"key":"77164_CR17","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1111\/febs.12418","volume":"280","author":"CY Lee","year":"2013","unstructured":"Lee, C. Y., Cantle, J. P. & Yang, X. W. Genetic manipulations of mutant huntingtin in mice: new insights into Huntington.s disease pathogenesis. FEBS J. 280, 4382\u20134394. https:\/\/doi.org\/10.1111\/febs.12418 (2013).","journal-title":"FEBS J."},{"key":"77164_CR18","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1021\/acs.jproteome.6b00991","volume":"16","author":"T Ratovitski","year":"2017","unstructured":"Ratovitski, T. et al. Post-translational modifications (PTMs), identified on endogenous huntingtin, cluster within proteolytic domains between HEAT repeats. J. Proteome Res. 16, 2692\u20132708. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00991 (2017).","journal-title":"J. Proteome Res."},{"key":"77164_CR19","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1038\/ncomms7768","volume":"6","author":"MMP Pearce","year":"2015","unstructured":"Pearce, M. M. P., Spartz, E. J., Hong, W., Luo, L. & Kopito, R. R. Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain. Nat. Commun. 6, 6768. https:\/\/doi.org\/10.1038\/ncomms7768 (2015).","journal-title":"Nat. Commun."},{"key":"77164_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1084\/jem.20120741","volume":"209","author":"M Polymenidou","year":"2012","unstructured":"Polymenidou, M. & Cleveland, D. W. Prion-like spread of protein aggregates in neurodegeneration. J. Exp. Med. 209, 889\u2013893. https:\/\/doi.org\/10.1084\/jem.20120741 (2012).","journal-title":"J. Exp. Med."},{"key":"77164_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nsmb.1570","volume":"16","author":"AK Thakur","year":"2009","unstructured":"Thakur, A. K. et al. Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol. 16, 380\u2013389. https:\/\/doi.org\/10.1038\/nsmb.1570 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77164_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ncb1830","volume":"11","author":"PH Ren","year":"2009","unstructured":"Ren, P. H. et al. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol. 11, 219\u2013225. https:\/\/doi.org\/10.1038\/ncb1830 (2009).","journal-title":"Nat. Cell Biol."},{"key":"77164_CR23","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1093\/hmg\/11.23.2905","volume":"11","author":"W Yang","year":"2002","unstructured":"Yang, W., Dunlap, J. R., Andrews, R. B. & Wetzel, R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 11, 2905\u20132917. https:\/\/doi.org\/10.1093\/hmg\/11.23.2905 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"77164_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.molcel.2018.07.032","volume":"71","author":"A Ast","year":"2018","unstructured":"Ast, A. et al. mHTT seeding activity: a marker of disease progression and neurotoxicity in models of Huntington\u2019s disease. Mol. Cell 71, 675\u2013688. https:\/\/doi.org\/10.1016\/j.molcel.2018.07.032 (2018).","journal-title":"Mol. Cell"},{"key":"77164_CR25","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.febslet.2015.05.041","volume":"589","author":"OA Morozova","year":"2015","unstructured":"Morozova, O. A., Gupta, S. & Colby, D. W. Prefibrillar huntingtin oligomers isolated from HD brain potently seed amyloid formation. FEBS Lett. 589, 1897\u20131903. https:\/\/doi.org\/10.1016\/j.febslet.2015.05.041 (2015).","journal-title":"FEBS Lett."},{"key":"77164_CR26","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/mp.2015.81","volume":"20","author":"Z Tan","year":"2015","unstructured":"Tan, Z. et al. Huntington\u2019s disease cerebrospinal fluid seeds aggregation of mutant huntingtin. Mol. Psychiatry 20, 1286\u20131293. https:\/\/doi.org\/10.1038\/mp.2015.81 (2015).","journal-title":"Mol. Psychiatry"},{"key":"77164_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajhg.2015.12.018","volume":"98","author":"JW Keum","year":"2016","unstructured":"Keum, J. W. et al. The HTT CAG-expansion mutation determines age at death but not disease duration in huntington disease. Am. J. Hum. Genet. 98, 287\u2013298. https:\/\/doi.org\/10.1016\/j.ajhg.2015.12.018 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"77164_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.chembiol.2010.03.011","volume":"17","author":"YM Ramdzan","year":"2010","unstructured":"Ramdzan, Y. M. et al. Conformation sensors that distinguish monomeric proteins from oligomers in live cells. Chem. Biol. 17, 371\u2013379. https:\/\/doi.org\/10.1016\/j.chembiol.2010.03.011 (2010).","journal-title":"Chem. Biol."},{"key":"77164_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.neuron.2015.01.008","volume":"85","author":"X Gu","year":"2015","unstructured":"Gu, X. et al. N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice. Neuron 85, 726\u2013741. https:\/\/doi.org\/10.1016\/j.neuron.2015.01.008 (2015).","journal-title":"Neuron"},{"key":"77164_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18065","author":"K Shen","year":"2016","unstructured":"Shen, K. et al. Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract. eLife https:\/\/doi.org\/10.7554\/eLife.18065 (2016).","journal-title":"eLife"},{"key":"77164_CR31","doi-asserted-by":"publisher","first-page":"20075","DOI":"10.1073\/pnas.1320626110","volume":"110","author":"SL Crick","year":"2013","unstructured":"Crick, S. L., Ruff, K. M., Garai, K., Frieden, C. & Pappu, R. V. Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation. Proc. Natl. Acad. Sci. U. S. A. 110, 20075\u201320080. https:\/\/doi.org\/10.1073\/pnas.1320626110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"77164_CR32","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","volume":"64","author":"X Gu","year":"2009","unstructured":"Gu, X. et al. Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron 64, 828\u2013840. https:\/\/doi.org\/10.1016\/j.neuron.2009.11.020 (2009).","journal-title":"Neuron"},{"key":"77164_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmb.2012.09.011","volume":"424","author":"R Mishra","year":"2012","unstructured":"Mishra, R. et al. Serine phosphorylation suppresses huntingtin amyloid accumulation by altering protein aggregation properties. J. Mol. Biol. 424, 1\u201314. https:\/\/doi.org\/10.1016\/j.jmb.2012.09.011 (2012).","journal-title":"J. Mol. Biol."},{"key":"77164_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-015-0063-2","volume":"10","author":"MB Veldman","year":"2015","unstructured":"Veldman, M. B. et al. The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington\u2019s disease model. Mol. Neurodegener 10, 67. https:\/\/doi.org\/10.1186\/s13024-015-0063-2 (2015).","journal-title":"Mol. Neurodegener"},{"key":"77164_CR35","doi-asserted-by":"publisher","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen, T. et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 7, e50717. https:\/\/doi.org\/10.1371\/journal.pone.0050717 (2012).","journal-title":"PLoS ONE"},{"key":"77164_CR36","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled, L. B. et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE 7, e49838. https:\/\/doi.org\/10.1371\/journal.pone.0049838 (2012).","journal-title":"PLoS ONE"},{"key":"77164_CR37","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","volume":"23","author":"GA Smith","year":"2014","unstructured":"Smith, G. A. et al. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease. Hum. Mol. Genet. 23, 4510\u20134527. https:\/\/doi.org\/10.1093\/hmg\/ddu166 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"77164_CR38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nn.4256","volume":"19","author":"P Langfelder","year":"2016","unstructured":"Langfelder, P. et al. Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nat. Neurosci. 19, 623\u2013633. https:\/\/doi.org\/10.1038\/nn.4256 (2016).","journal-title":"Nat. Neurosci."},{"key":"77164_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel, J. P. et al. Neuropathological classification of Huntington\u2019s disease. J. Neuropathol. Exp. Neurol. 44, 559\u2013577. https:\/\/doi.org\/10.1097\/00005072-198511000-00003 (1985).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"77164_CR40","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/mds.26364","volume":"30","author":"JD Long","year":"2015","unstructured":"Long, J. D., Paulsen, J. S., Investigators, P.-H. & Coordinators of the Huntington Study, G. Multivariate prediction of motor diagnosis in Huntington\u2019s disease: 12 years of PREDICT-HD. Mov. Disord. 30, 1664\u20131672. https:\/\/doi.org\/10.1002\/mds.26364 (2015).","journal-title":"Mov. Disord."},{"key":"77164_CR41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross, C. A. et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 10, 204\u2013216. https:\/\/doi.org\/10.1038\/nrneurol.2014.24 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"77164_CR42","doi-asserted-by":"publisher","first-page":"17225","DOI":"10.1074\/jbc.M112.421685","volume":"288","author":"J Gillis","year":"2013","unstructured":"Gillis, J. et al. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides. J. Biol. Chem. 288, 17225\u201317237. https:\/\/doi.org\/10.1074\/jbc.M112.421685 (2013).","journal-title":"J. Biol. Chem."},{"key":"77164_CR43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.molcel.2016.03.017","volume":"62","author":"V Kakkar","year":"2016","unstructured":"Kakkar, V. et al. The S\/T-Rich Motif in the DNAJB6 chaperone delays polyglutamine aggregation and the onset of disease in a mouse model. Mol. Cell 62, 272\u2013283. https:\/\/doi.org\/10.1016\/j.molcel.2016.03.017 (2016).","journal-title":"Mol. Cell"},{"key":"77164_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra, K. et al. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80, 402\u2013414. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.046 (2013).","journal-title":"Neuron"},{"key":"77164_CR45","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","volume":"46","author":"E Masliah","year":"2005","unstructured":"Masliah, E. et al. Effects of alpha-synuclein immunization in a mouse model of Parkinson\u2019s disease. Neuron 46, 857\u2013868. https:\/\/doi.org\/10.1016\/j.neuron.2005.05.010 (2005).","journal-title":"Neuron"},{"key":"77164_CR46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JHD-170269","volume":"6","author":"V Fodale","year":"2017","unstructured":"Fodale, V. et al. Validation of ultrasensitive mutant huntingtin detection in human cerebrospinal fluid by single molecule counting immunoassay. J. Huntingtons Dis. 6, 349\u2013361. https:\/\/doi.org\/10.3233\/JHD-170269 (2017).","journal-title":"J. Huntingtons Dis."},{"key":"77164_CR47","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nsmb.1700","volume":"16","author":"S Tam","year":"2009","unstructured":"Tam, S. et al. The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation. Nat. Struct. Mol. Biol. 16, 1279\u20131285. https:\/\/doi.org\/10.1038\/nsmb.1700 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77164_CR48","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1073\/pnas.022631799","volume":"99","author":"A Khoshnan","year":"2002","unstructured":"Khoshnan, A., Ko, J. & Patterson, P. H. Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity. Proc. Natl. Acad. Sci. U. S. A. 99, 1002\u20131007. https:\/\/doi.org\/10.1073\/pnas.022631799 (2002).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"77164_CR49","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1093\/hmg\/ddy141","volume":"27","author":"J Ko","year":"2018","unstructured":"Ko, J. et al. Identification of distinct conformations associated with monomers and fibril assemblies of mutant huntingtin. Hum. Mol. Genet. 27, 2330\u20132343. https:\/\/doi.org\/10.1093\/hmg\/ddy141 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"77164_CR50","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1523\/JNEUROSCI.2747-08.2008","volume":"28","author":"AL Southwell","year":"2008","unstructured":"Southwell, A. L. et al. Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity. J. Neurosci. 28, 9013\u20139020. https:\/\/doi.org\/10.1523\/JNEUROSCI.2747-08.2008 (2008).","journal-title":"J. Neurosci."},{"key":"77164_CR51","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1021\/acs.biochem.5b00281","volume":"54","author":"JM Isas","year":"2015","unstructured":"Isas, J. M., Langen, R. & Siemer, A. B. Solid-state nuclear magnetic resonance on the static and dynamic domains of huntingtin exon-1 fibrils. Biochemistry 54, 3942\u20133949. https:\/\/doi.org\/10.1021\/acs.biochem.5b00281 (2015).","journal-title":"Biochemistry"},{"key":"77164_CR52","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1074\/jbc.M117.813667","volume":"293","author":"NK Pandey","year":"2018","unstructured":"Pandey, N. K. et al. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms. J. Biol. Chem. 293, 2597\u20132605. https:\/\/doi.org\/10.1074\/jbc.M117.813667 (2018).","journal-title":"J. Biol. Chem."},{"key":"77164_CR53","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/archneur.63.6.883","volume":"63","author":"JS Paulsen","year":"2006","unstructured":"Paulsen, J. S. et al. Preparing for preventive clinical trials: the Predict-HD study. Arch. Neurol. 63, 883\u2013890. https:\/\/doi.org\/10.1001\/archneur.63.6.883 (2006).","journal-title":"Arch. Neurol."},{"key":"77164_CR54","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1212\/WNL.0000000000004844","volume":"90","author":"ER Reed","year":"2018","unstructured":"Reed, E. R. et al. MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study. Neurology 90, e264\u2013e272. https:\/\/doi.org\/10.1212\/WNL.0000000000004844 (2018).","journal-title":"Neurology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77164-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77164-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77164-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:44:33Z","timestamp":1670370273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77164-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77164"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77164-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,20]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20295"}}